Country Reports — Market Intelligence by Geography

Markets NXT — A Montclaire & Stein Venture

A Century of Global Intelligence Behind Every Report

Markets NXT builds on a legacy dating to the early 1900s, when economists Edgar Montclaire and Johann Stein began advising enterprises across Europe and North America on industrial expansion and globalization. Over more than a century, Montclaire & Stein accumulated institutional knowledge spanning economic intelligence and market dynamics across geographies — forming the analytical foundation behind every report we publish today.

Why Country-Level Intelligence Matters

Global markets are not uniform. Regulatory environments, consumer behavior, industrial composition, and competitive dynamics differ significantly by country. Country-specific research helps businesses:

  • Accurately size and forecast a market within a defined geography
  • Understand local demand drivers, supply chains, and competition
  • Navigate country-specific regulatory and policy frameworks
  • Identify entry points, opportunities, and risk factors at a national level

What Our Country Reports Cover

Each report delivers institutional-grade intelligence across: market sizing and forecasting, industry segmentation, competitive landscape, regulatory environment, macroeconomic context, and strategic recommendations — all grounded in conservative, multi-source validated methodology.

Institutional Rigour at the Most Competitive Pricing

Markets NXT offers country-specific research at the most competitive pricing in the industry, without compromising analytical standards. Our reports serve growth-stage businesses, investment firms, and consulting teams that need board-level intelligence without enterprise-level costs.

Explore Reports by Country

Browse and filter below to find market research reports for the country of your interest. Coverage spans North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa.

Showing 31 - 40 of 2762 reports

U.S. Anti-Nuclear Antibody Testing Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.42 Billion Market Size 2032: USD 2.61 Billion CAGR: 7.9% Market Definition: The U.S. anti-nuclear antibody (ANA) testing market encompasses diagnostic assays, instruments, and laboratory services used to detect autoantibodies targeting nuclear antigens, primarily for diagnosis and monitoring of … Read More
Published September 2026

U.S. ELISPOT and FluoroSpot Assay Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 198.4 million Market Size 2032: USD 374.7 million CAGR: 8.3% Market Definition: The U.S. ELISPOT and FluoroSpot assay market encompasses reagent kits, plate systems, readers, and software used to detect and quantify cytokine-secreting cells at the single-cell level, applied … Read More
Published September 2026

U.S. Drug Screening Market Size, Share & Forecast 2026–2034

Report Highlights Country: United States Market: Drug Screening Market Size 2024: USD 4.1 billion Market Size 2032: USD 7.6 billion CAGR: 8.0% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Oral Fluid Testing Surge: Quest Diagnostics reported a 34% year-over-year … Read More
Published September 2026

U.S. Desalting and Buffer Exchange Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 412.6 million Market Size 2032: USD 748.3 million CAGR: 7.7% Market Definition: The U.S. desalting and buffer exchange market encompasses products and systems used to remove salts, small molecules, and exchange buffer conditions in biological samples, including spin columns, … Read More
Published September 2026

U.S. Contrast Media Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 2.1 Billion Market Size 2032: USD 3.4 Billion CAGR: 6.2% Market Definition: The U.S. contrast media market encompasses iodinated, gadolinium-based, microbubble, and other contrast agents used in diagnostic imaging procedures including CT, MRI, ultrasound, and fluoroscopy across hospital, outpatient, … Read More
Published September 2026

U.S. Blood Transfusion Diagnostics Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.82 billion Market Size 2032: USD 3.14 billion CAGR: 7.1% Market Definition: The U.S. blood transfusion diagnostics market encompasses products and services used to ensure blood safety and compatibility, including blood typing, infectious disease screening, cross-matching, and antibody identification … Read More
Published September 2026

U.S. Blood Coagulation Testing Market Size, Share & Forecast 2026–2034

Report Highlights Country: United States Market: Blood Coagulation Testing Market Size 2024: USD 2.8 Billion Market Size 2032: USD 4.6 Billion CAGR: 6.4% Base Year: 2025 Forecast Period: 2026–2032 Analyst Findings and Recommendations Finding 01 — Point-of-Care Displacement Accelerating: Roche Diagnostics' CoaguChek XS platform now … Read More
Published September 2026

U.S. Biobanking Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 3.2 Billion Market Size 2032: USD 7.9 Billion CAGR: 12.1% Market Definition: The U.S. biobanking market encompasses the collection, processing, storage, and distribution of biological specimens including blood, tissue, cells, and DNA for research, diagnostics, and therapeutic development. It … Read More
Published September 2026

U.S. Apoptosis Assays Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: USD 1.42 Billion Market Size 2032: USD 2.89 Billion CAGR: 9.3% Market Definition: The U.S. apoptosis assays market encompasses reagents, kits, instruments, and services used to detect, measure, and characterize programmed cell death in research and clinical applications. It serves … Read More
Published September 2026

United States Biomarker Market Size, Share & Forecast 2026–2034

Report Highlights Market Size 2024: $11.4 billion Market Size 2034: $28.7 billion CAGR: 9.7% Market Definition: The United States biomarker market encompasses the discovery, validation, and commercial application of biological indicators — including genomic, proteomic, and imaging biomarkers — used across drug development, diagnostics, and … Read More
Published September 2026